再次肝切除术与射频消融治疗亚洲复发性肝细胞癌患者效果比较的Meta分析

目的 使用Meta分析的方法比较再次肝切除术与射频消融治疗亚洲复发性肝癌患者的安全性与疗效。 方法 系统检索PubMed、中国知网和万方数据库,日期自建库截止至2020年6月15日。由两位评价者独立检索并提取数据,采用RevMan 5.4.1软件进行Meta分析。 结果 共2项随机对照试验和18项回顾性队列研究符合纳入标准,均来自亚洲国家,包含2903例复发性肝癌患者。再次肝切除术组和射频消融组患者围手术期病死率分别为2%和0,围手术期并发症发生率分别为22.4%和3.3%。再次肝切除术组和射频消融组患者术后1、3、5年总生存率分别为92.3%、66.3%、51.1%和91.4%、69.2%、...

Full description

Saved in:
Bibliographic Details
Published inLinchuang gandanbing zazhi Vol. 37; no. 5; pp. 1103 - 1109
Main Authors 李旻骏, 邓柱鉴, 刘昊天, 滕煜宪, 霍荣瑞, 梁秀妹, 向邦德, 黎乐群, 钟鉴宏
Format Journal Article
LanguageChinese
Published Changchun Journal of Clinical Hepatology 01.01.2021
广西医科大学附属肿瘤医院肝胆外科,广西肝癌诊疗工程技术研究中心,南宁530021
Subjects
Online AccessGet full text
ISSN1001-5256
2097-3497
DOI10.3969/j.issn.1001-5256.2021.05.025

Cover

Abstract 目的 使用Meta分析的方法比较再次肝切除术与射频消融治疗亚洲复发性肝癌患者的安全性与疗效。 方法 系统检索PubMed、中国知网和万方数据库,日期自建库截止至2020年6月15日。由两位评价者独立检索并提取数据,采用RevMan 5.4.1软件进行Meta分析。 结果 共2项随机对照试验和18项回顾性队列研究符合纳入标准,均来自亚洲国家,包含2903例复发性肝癌患者。再次肝切除术组和射频消融组患者围手术期病死率分别为2%和0,围手术期并发症发生率分别为22.4%和3.3%。再次肝切除术组和射频消融组患者术后1、3、5年总生存率分别为92.3%、66.3%、51.1%和91.4%、69.2%、39.9%。两组患者术后1、3、5年无瘤生存率分别为67.9%、48.3%、34.4%和57.5%、27.9%、14.0%。Meta分析结果提示,两组患者的总生存率差异无统计学意义(HR=0.89,95%CI:0.77~1.02,P=0.10),但再次肝切除术组患者的无瘤生存率显著高于射频消融组(HR=0.79,95%CI:0.72~0.87,P<0.001)。 结论 目前证据显示,再次肝切除术治疗复发性肝癌有更高的无瘤生存率,但两组患者的总生存率相似。
AbstractList 目的 使用Meta分析的方法比较再次肝切除术与射频消融治疗亚洲复发性肝癌患者的安全性与疗效。 方法 系统检索PubMed、中国知网和万方数据库,日期自建库截止至2020年6月15日。由两位评价者独立检索并提取数据,采用RevMan 5.4.1软件进行Meta分析。 结果 共2项随机对照试验和18项回顾性队列研究符合纳入标准,均来自亚洲国家,包含2903例复发性肝癌患者。再次肝切除术组和射频消融组患者围手术期病死率分别为2%和0,围手术期并发症发生率分别为22.4%和3.3%。再次肝切除术组和射频消融组患者术后1、3、5年总生存率分别为92.3%、66.3%、51.1%和91.4%、69.2%、39.9%。两组患者术后1、3、5年无瘤生存率分别为67.9%、48.3%、34.4%和57.5%、27.9%、14.0%。Meta分析结果提示,两组患者的总生存率差异无统计学意义(HR=0.89,95%CI:0.77~1.02,P=0.10),但再次肝切除术组患者的无瘤生存率显著高于射频消融组(HR=0.79,95%CI:0.72~0.87,P<0.001)。 结论 目前证据显示,再次肝切除术治疗复发性肝癌有更高的无瘤生存率,但两组患者的总生存率相似。
R735.7; 目的 使用Meta分析的方法比较再次肝切除术与射频消融治疗亚洲复发性肝癌患者的安全性与疗效.方法 系统检索PubMed、中国知网和万方数据库,日期自建库截止至2020年6月15日.由两位评价者独立检索并提取数据,采用RevMan 5.4.1软件进行Meta分析.结果 共2项随机对照试验和18项回顾性队列研究符合纳入标准,均来自亚洲国家,包含2903例复发性肝癌患者.再次肝切除术组和射频消融组患者围手术期病死率分别为2%和0,围手术期并发症发生率分别为22.4%和3.3%.再次肝切除术组和射频消融组患者术后1、3、5年总生存率分别为92.3%、66.3%、51.1%和91.4%、69.2%、39.9%.两组患者术后1、3、5年无瘤生存率分别为67.9%、48.3%、34.4%和57.5%、27.9%、14.0%.Meta分析结果提示,两组患者的总生存率差异无统计学意义(HR=0.89,95%CI:0.77~1.02,P=0.10),但再次肝切除术组患者的无瘤生存率显著高于射频消融组(HR=0.79,95%CI:0.72~0.87,P<0.001).结论 目前证据显示,再次肝切除术治疗复发性肝癌有更高的无瘤生存率,但两组患者的总生存率相似.
Author 李旻骏
刘昊天
钟鉴宏
黎乐群
邓柱鉴
滕煜宪
梁秀妹
霍荣瑞
向邦德
AuthorAffiliation 广西医科大学附属肿瘤医院肝胆外科,广西肝癌诊疗工程技术研究中心,南宁530021
AuthorAffiliation_xml – name: 广西医科大学附属肿瘤医院肝胆外科,广西肝癌诊疗工程技术研究中心,南宁530021
Author_FL HUO Rongrui
TENG Yuxian
LIANG Xiumei
LI Lequn
LI Minjun
ZHONG Jianhong
XIANG Bangde
DENG Zhujian
LIU Haotian
Author_FL_xml – sequence: 1
  fullname: LI Minjun
– sequence: 2
  fullname: DENG Zhujian
– sequence: 3
  fullname: LIU Haotian
– sequence: 4
  fullname: TENG Yuxian
– sequence: 5
  fullname: HUO Rongrui
– sequence: 6
  fullname: LIANG Xiumei
– sequence: 7
  fullname: XIANG Bangde
– sequence: 8
  fullname: LI Lequn
– sequence: 9
  fullname: ZHONG Jianhong
Author_xml – sequence: 1
  fullname: 李旻骏
– sequence: 2
  fullname: 邓柱鉴
– sequence: 3
  fullname: 刘昊天
– sequence: 4
  fullname: 滕煜宪
– sequence: 5
  fullname: 霍荣瑞
– sequence: 6
  fullname: 梁秀妹
– sequence: 7
  fullname: 向邦德
– sequence: 8
  fullname: 黎乐群
– sequence: 9
  fullname: 钟鉴宏
BookMark eNpF0M1KAlEUB_BLFGTmU9SizUxn7jj3zl2G9AVGG_cyM86IIqM5SuBK1GwWWQl9oJhQCW0CQyIioadxruNbNGIUZ3HO4sc5h_8aWrbztonQpgSizAjbzooZx7FFCUASFKwQEQOWRFBEwMoSCmFgVJCjjC6j0J9ZRRHHyeigSDJhUYWEkOY1W_z10a89eO75rDPgveHk89J7a8ye2vzD9fstPhpP7-4nX13-PvIGLe-qzasvgZ-Om369P-1c8NqzXz3jty7v9_jwxv-uT7uNI7OkeW6T96_X0Yql5Rwz8tvDKLG3m4gdCPHj_cPYTlwoEIkIKVXVGRAVWMpMqSbDigXzWaI4-JUGRSyVGmAxWTMMMExLB10jhEqU6hpYchhtLdaearal2elkNl8u2sHBZM5Ip_RKZR4PKIBJQDcWtFDMn5RNp_RvZSwzSqIEq_IPpa2JAA
ClassificationCodes R735.7
ContentType Journal Article
Copyright 2021. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: 2021. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.3969/j.issn.1001-5256.2021.05.025
DatabaseName ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni)
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database (Proquest)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitle Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
DatabaseTitleList Publicly Available Content Database

Database_xml – sequence: 1
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitle_FL Clinical effect of re-hepatic resection versus radiofrequency ablation in treatment of recurrent hepatocellular carci- noma in Asia:A Meta-analysis
EISSN 2097-3497
EndPage 1109
ExternalDocumentID lcgdbzz202105026
GeographicLocations Asia
GeographicLocations_xml – name: Asia
GrantInformation_xml – fundername: (国家自然科学基金); (广西自然科学基金); ("广西八桂学者"专项经费); (中国博士后科学基金); 广西高等学校高水平创新团队及卓越学者计划
  funderid: (国家自然科学基金); (广西自然科学基金); ("广西八桂学者"专项经费); (中国博士后科学基金); 广西高等学校高水平创新团队及卓越学者计划
GroupedDBID -05
3V.
5XA
5XF
7X7
7XB
88E
8FI
8FJ
8FK
92F
92I
ABDBF
ABJNI
ABUWG
ACGFS
ACUHS
AFKRA
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BENPR
CCEZO
CCPQU
CIEJG
CW9
DWQXO
EAD
EAP
EOJEC
ESX
FYUFA
K9.
M1P
OBODZ
OK1
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
RNS
TCJ
TGQ
U1G
U5O
2B.
4A8
93N
IPNFZ
PSX
RIG
ID FETCH-LOGICAL-p616-d88b906809ded8e925f009de17213676766f87c0f93acc0cefb0ba667177ba0f3
IEDL.DBID 7X7
ISSN 1001-5256
IngestDate Thu May 29 04:06:09 EDT 2025
Sat Aug 23 12:56:27 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords 肝切除术
Meta分析(主题)
射频消融
癌,肝细胞
Language Chinese
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-p616-d88b906809ded8e925f009de17213676766f87c0f93acc0cefb0ba667177ba0f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
OpenAccessLink https://www.proquest.com/docview/3239764628?pq-origsite=%requestingapplication%
PQID 3239764628
PQPubID 7350069
PageCount 7
ParticipantIDs wanfang_journals_lcgdbzz202105026
proquest_journals_3239764628
PublicationCentury 2000
PublicationDate 20210101
2021
PublicationDateYYYYMMDD 2021-01-01
PublicationDate_xml – month: 01
  year: 2021
  text: 20210101
  day: 01
PublicationDecade 2020
PublicationPlace Changchun
PublicationPlace_xml – name: Changchun
PublicationTitle Linchuang gandanbing zazhi
PublicationTitle_FL Journal of Clinical Hepatology
PublicationYear 2021
Publisher Journal of Clinical Hepatology
广西医科大学附属肿瘤医院肝胆外科,广西肝癌诊疗工程技术研究中心,南宁530021
Publisher_xml – name: Journal of Clinical Hepatology
– name: 广西医科大学附属肿瘤医院肝胆外科,广西肝癌诊疗工程技术研究中心,南宁530021
SSID ssib051369456
ssib061082477
ssj0041983
ssib001103858
ssib053243598
ssib002264326
ssib038074677
Score 2.2230787
Snippet 目的 使用Meta分析的方法比较再次肝切除术与射频消融治疗亚洲复发性肝癌患者的安全性与疗效。 方法 系统检索PubMed、中国知网和万方数据库,日期自建库截止至2020年6月15日。由两位评价者独立检索并提取数据,采用RevMan 5.4.1软件进行Meta分析。 结果...
R735.7; 目的 使用Meta分析的方法比较再次肝切除术与射频消融治疗亚洲复发性肝癌患者的安全性与疗效.方法 系统检索PubMed、中国知网和万方数据库,日期自建库截止至2020年6月15日.由两位评价者独立检索并提取数据,采用RevMan 5.4.1软件进行Meta分析.结果...
SourceID wanfang
proquest
SourceType Aggregation Database
StartPage 1103
SubjectTerms Ablation
Liver cancer
Meta-analysis
Title 再次肝切除术与射频消融治疗亚洲复发性肝细胞癌患者效果比较的Meta分析
URI https://www.proquest.com/docview/3239764628
https://d.wanfangdata.com.cn/periodical/lcgdbzz202105026
Volume 37
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTE2Sk1OMkzVNUs0MNc1SU5M1k0CNvV1Dc3M00zMEpNTDVJBG5x9_cw8Qk28IkwjoANuxdBllbAyEVxQp-Qng8bI9Y2NQDUnaCelfUGhLujWKNDsKvQKDWYGVvDRZcD0bB6BqE4NDQ1QzmoBbRpFaq6Azlo3QTrOzdTQ2MzSBHG2jCmwsQE64A7GB7Y0LIzA-zYhJb0JsMMOWcAP7JKbAtsOHAwqoF6wpZmlfhY4D-vBpYA9USND8BmhRqYojVn28sS8tMS8dKRazU2QgR_aHFVwhKQfIQamqgxhBg5f6IS7CEPi07beZ2sWvmia-7Sj_eXMJc_mrH-yo-_phpaXiyY-29bxYl7vs027n0-b_mTXrGdbNj1d0vu0f-KzhuVA9c93t71onvd8Zs-zpsUvGlqfTe14Nm_Os_VTXuxrfj6rxTe1JPFpR9uzeRNEGULcXEOcPXShtzLoFpgZmummWFgkWYIu7LBMSU2xSLU0Mk0zALFBXUnw6W9mZmkW5skGaZbGicnJBsmpaUkGSYlmZsBuo3lSokGasRgDS15-XqoEg4KFeUqqqUWKmbFJsrFJKtBYoLR5apI5qJRIMzY3kmSQgYVTPDRnFccj0oEkgyI07BCyOcnpKUlVVaDANjAFpjkp_EZIM3CBlEKGVGQYWEqKSlNlgY2MkiQ5cEqSY2B1dHJxcgPSTq5-AUEAOQzm_A
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTE2Sk1OMkzVNUs0MNc1SU5M1k0CNvV1Dc3M00zMEpNTDVJBG5x9_cw8Qk28IkwjmBjWwvbCgJZVwspEcEGdkp8MGiPXNzYC1ZygnZT2BYW6oFujQLOrsCs0IMnCO7WyHNhlK7b1dAHGr6qRkZtriLOHLvRWAd0CM0Mz3RQLiyRL0IUTlimpKRaplkamaQYgNqgrBD69zMwszcI82SDN0jgxOdkgOTUtySAp0cwM2O0xT0o0SDMGGsvMwGoC2tDKwsDq5OoXEIRofxgaoBwOA9qlitQ-Ah3uboJ0fpwp0EZLE8RhNqbA1g3oRD0YH9i0sTACbxSFVC0mhpYWkB0DBobAHqSpGQeDCqjbbWlmqZ8FLjT04FLArq-RIfhQUiNTlNYze3liXlpiXjpSNeomyMAPbf8qOEISrBADU1WGMAOHL3SGX4Qh8Wlb77M1C180zX3a0f5y5pJnc9Y_2dH3dEPLy0UTn23reDGv99mm3c-nTX-ya9azLZueLul92j_xWcNyoPrnu9teNM97PrPnWdPiFw2tz6Z2PJs359n6KS_2NT-f1eKbWpL4tKPt2bwJogwhtIgwMQaWvPy8VAkGBQvzlFRTixQzY5NkY5NUoLFAafPUJHNQsZRmbG4kySADC6d4aFYujkckPEkGRWjYIWRzktNTkqqqQIFtYApM5FL4jZBn4PQI8fWJ9_H085Zm4AJpg4znyDCwlBSVpsoCWzglSXLQdKXAEE_jlAwAMqshcg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E5%86%8D%E6%AC%A1%E8%82%9D%E5%88%87%E9%99%A4%E6%9C%AF%E4%B8%8E%E5%B0%84%E9%A2%91%E6%B6%88%E8%9E%8D%E6%B2%BB%E7%96%97%E4%BA%9A%E6%B4%B2%E5%A4%8D%E5%8F%91%E6%80%A7%E8%82%9D%E7%BB%86%E8%83%9E%E7%99%8C%E6%82%A3%E8%80%85%E6%95%88%E6%9E%9C%E6%AF%94%E8%BE%83%E7%9A%84Meta%E5%88%86%E6%9E%90&rft.jtitle=%E4%B8%B4%E5%BA%8A%E8%82%9D%E8%83%86%E7%97%85%E6%9D%82%E5%BF%97&rft.au=%E6%9D%8E%E6%97%BB%E9%AA%8F&rft.au=%E9%82%93%E6%9F%B1%E9%89%B4&rft.au=%E5%88%98%E6%98%8A%E5%A4%A9&rft.au=%E6%BB%95%E7%85%9C%E5%AE%AA&rft.date=2021&rft.pub=%E5%B9%BF%E8%A5%BF%E5%8C%BB%E7%A7%91%E5%A4%A7%E5%AD%A6%E9%99%84%E5%B1%9E%E8%82%BF%E7%98%A4%E5%8C%BB%E9%99%A2%E8%82%9D%E8%83%86%E5%A4%96%E7%A7%91%2C%E5%B9%BF%E8%A5%BF%E8%82%9D%E7%99%8C%E8%AF%8A%E7%96%97%E5%B7%A5%E7%A8%8B%E6%8A%80%E6%9C%AF%E7%A0%94%E7%A9%B6%E4%B8%AD%E5%BF%83%2C%E5%8D%97%E5%AE%81530021&rft.issn=1001-5256&rft.volume=37&rft.issue=5&rft.spage=1103&rft.epage=1109&rft_id=info:doi/10.3969%2Fj.issn.1001-5256.2021.05.025&rft.externalDocID=lcgdbzz202105026
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Flcgdbzz%2Flcgdbzz.jpg